Michala E.F. Pedersen et al. JACEP 2016;j.jacep

Slides:



Advertisements
Similar presentations
RE-CIRCUIT Trial design: Patients with atrial fibrillation undergoing catheter ablation were randomized to uninterrupted dabigatran 150 mg twice daily.
Advertisements

Michala E.F. Pedersen et al. JACEP 2017;3:
Oana Dickinson et al. JACEP 2016;2:
Prakash Harikrishnan et al. JACEP 2015;1:
Prakash Harikrishnan et al. JACEP 2015;1:
Suggested approach to patients with dabigatran-associated bleeding
Noriko Kikuchi et al. JACEP 2016;2:
Steven E. Williams et al. JACEP 2015;1:
Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.
Waddah Maskoun et al. JACEP 2016;2:
Konstantinos C. Siontis et al. JACEP 2016;2:
Pablo Ávila et al. JACEP 2015;1:
Jose C. Pachon M. et al. JACEP 2015;1:
Shadi Al Halabi et al. JACEP 2015;1:
Pugazhendhi Vijayaraman et al. JACEP 2015;1:
Kenshi Hayashi et al. JACEP 2016;2:
Ashish Shukla et al. JACEP 2015;1:41-51
Takekuni Hayashi et al. JACEP 2016;2:27-35
Pugazhendhi Vijayaraman et al. JACEP 2015;1:
Thomas C. Crawford et al. JACEP 2017;3:
Thomas C. Crawford et al. JACEP 2017;j.jacep
Jong Sung Park et al. JACEP 2016;2:
Julien Seitz et al. JACEP 2016;2:
Jose C. Pachon M. et al. JACEP 2015;1:
Adam B. Greenbaum et al. JACEP 2015;1:
David F. Katz et al. JACEP 2016;j.jacep
Sébastien P.J. Krul et al. JACEP 2015;1:
Mitsuharu Kawamura et al. JACEP 2016;2:
Samuel H. Baldinger et al. JACEP 2016;2:14-23
Dhanunjaya Lakkireddy et al. JACEP 2015;1:
Mintu P. Turakhia et al. JACEP 2016;2:
Pablo Ávila et al. JACEP 2015;1:
Junaid A.B. Zaman et al. JACEP 2017;3:
Adam B. Greenbaum et al. JACEP 2015;1:
Jong Sung Park et al. JACEP 2016;2:
Konstantin Krieger et al. JACEP 2017;j.jacep
Stavros Stavrakis et al. JACEP 2015;1:1-13
Prakash Harikrishnan et al. JACEP 2015;1:
Mohit K. Turagam et al. JACEP 2017;3:
Eran Leshem et al. JACEP 2018;j.jacep
Moussa Mansour et al. JACEP 2017;3:
Mu Qin et al. JACEP 2017;j.jacep
M. Rizwan Afzal et al. JACEP 2017;3:
Adam B. Greenbaum et al. JACEP 2015;1:
Mintu P. Turakhia et al. JACEP 2016;2:
Leonard M. Rademakers et al. JACEP 2016;2:
Prakash Harikrishnan et al. JACEP 2015;1:
Mitsunori Maruyama et al. JACEP 2017;3:
Pouria Alipour et al. JACEP 2017;j.jacep
K.R. Julian Chun et al. JACEP 2017;3:
Philippe Taghji et al. JACEP 2017;j.jacep
Yoshitaka Kimura et al. JACEP 2016;2:
Vittorio Calzolari et al. JACEP 2017;3:
Kenshi Hayashi et al. JACEP 2016;2:
Stavros Stavrakis et al. JACEP 2015;1:1-13
Adam B. Greenbaum et al. JACEP 2015;1:
David F. Katz et al. JACEP 2017;3:20-28
Björn Redfors et al. JACEP 2017;j.jacep
P. Michael Grossman et al. JCIN 2009;2:
Moussa Mansour et al. JACEP 2016;j.jacep
Anna Björkenheim et al. JACEP 2017;j.jacep
Alexander Sedaghat et al. JACEP 2016;j.jacep
K.R. Julian Chun et al. JACEP 2017;3:
Matthew M. Zipse et al. JACEP 2015;1:94-102
Bernard Lim et al. JACEP 2016;2:
Adam B. Greenbaum et al. JACEP 2015;1:
Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep
Jose C. Pachon M. et al. JACEP 2015;1:
Vivek Y. Reddy et al. JACEP 2019;j.jacep
Henry Chubb et al. JACEP 2017;3:89-103
Presentation transcript:

Michala E.F. Pedersen et al. JACEP 2016;j.jacep.2016.09.016 Protocol for Early Removal of Pericardial Drain Complicating Atrial Fibrillation Catheter Ablation: Patient With Ongoing Bleeding Requiring Continuous Aspiration Needs Acute Referral From the Cardiac Surgeons If it is possible to drain the effusion to dryness, a period of monitoring should ensue. If there is no re-accumulation over a continuous observation period of at least 30 min, our findings suggest that the drain can be safely removed. The cycle may be repeated, but it is recommended that the drain is only removed after a minimum of 30 min to avoid re-accumulation. *Documented on transthoracic echocardiogram. **With prothrombin complex concentrate or Idarucizumab (Boehringer Ingelheim Pharmaceuticals). Michala E.F. Pedersen et al. JACEP 2016;j.jacep.2016.09.016 American College of Cardiology Foundation